Biocare Medical
Director of Quality Assurance
Thermo Fisher Scientific
Senior Quality Assurance Manager
Thermo Fisher Scientific Feb 1, 2007 - Feb 1, 2012
Quality Control Manager
Thermo Fisher Scientific Jan 1, 1997 - Feb 1, 2007
S Scientist, Project Leader, Manager For Product Development
Thermo Fisher Scientific Jan 1, 1997 - Feb 1, 2007
Qa Mger
Education:
University of Alberta 1985 - 1991
Doctorates, Doctor of Philosophy, Molecular Biology, Philosophy
Academic Institute of Science, Wuhan, China 1982 - 1985
Masters, Microbiology
Wuhan University 1978 - 1982
Bachelors, Bachelor of Science, Microbiology
Skills:
Capa Biotechnology Product Development Quality Control Immunoassays Molecular Biology Assay Development Quality Assurance Troubleshooting Recombinant Dna Technology Cell Culture Antibodies Molecular Virology Gmp Life Sciences Fda Medical Devices Corrective and Preventive Action Quality System Cross Functional Team Leadership Validation Glp
Languages:
English Mandarin
Us Patents
Reagents And Methods For Mycophenolic Acid Immunoassay
The invention teaches derivatives of mycophenolic alcohol and methods of preparing immunogens and other conjugates useful in immunoassays for quantitatively measuring concentrations of mycophenolic acid (MPA) and/or active metabolites of MPA in patient specimens. Antibodies produced from the disclosed immunogens capable of binding to MPA with cross-reactivity of no more than 5% with inactive metabolites and commonly co-prescribed drugs. Further, immunoassays for measuring the concentration of MPA using such antibodies are taught.
Chromogenic Substrate To Detect Urine Adulteration
Lakshmi Anne - Hayward CA, US Weixing Luo - Sunnyvale CA, US Ker-kong Tung - Del Mar CA, US
Assignee:
Applied Biotech, Inc.
International Classification:
C12Q001/26 C12Q001/28
US Classification:
435/025000
Abstract:
A device and method to detect oxidant adulterants added to a sample to prevent detection of tetrahydrocannabinol and/or tetrahydrocannabinol metabolites. The device and method detect popularly available adulterants such as chromate and nitrite through their reaction with a chromogenic substrate for a peroxidase enzyme. The substrate may be applied to a pad. A change in color in the presence of the oxidant may be detected directly or indirectly. The device and method may be used to detect the presence of any oxidant adulterant and is not specific for only one or a few adulterants added to a urine sample submitted for drug testing.